U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Hepatobiliary Disorders, CTCAE

MedGen UID:
1635015
•Concept ID:
C4553303
•
Finding

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVHepatobiliary Disorders, CTCAE

Professional guidelines

PubMed

Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients.
Meric-Bernstam F, Hollebecque A, Furuse J, Oh DY, Bridgewater JA, Shimura M, Anderson B, Hangai N, Wacheck V, Goyal L
Clin Cancer Res 2024 Apr 15;30(8):1466-1477. doi: 10.1158/1078-0432.CCR-23-2646. PMID: 38329716Free PMC Article
A Multi-centre, Single Arm, Non-randomized, Prospective European Trial to Evaluate the Safety and Efficacy of the HistoSonics System in the Treatment of Primary and Metastatic Liver Cancers (#HOPE4LIVER).
Wah TM, Pech M, Thormann M, Serres X, Littler P, Stenberg B, Lenton J, Smith J, Wiggermann P, Planert M, Vidal-Jove J, Torzilli G, Solbiati L
Cardiovasc Intervent Radiol 2023 Feb;46(2):259-267. Epub 2022 Nov 15 doi: 10.1007/s00270-022-03309-6. PMID: 36380155Free PMC Article
Camrelizumab and metronomic capecitabine for patients with treatment-refractory solid tumors (McCREST trial).
Zhou C, Shangguan C, Shi M, Xi W, Wu J, Yang H, Guo L, Cai Q, Shi Y, Liu J, Zhang J
Future Oncol 2022 Jul;18(23):2495-2503. Epub 2022 Jun 15 doi: 10.2217/fon-2021-1579. PMID: 35703115

Recent clinical studies

Etiology

Pancreatic injury in patients treated with immune checkpoint inhibitors: a retrospective multicenterstudy.
Nagao K, Sakai A, Tsumura H, Iemoto T, Hirata Y, Hori H, Ogisu K, Kakuyama S, Ikegawa T, Hirata T, Ezaki T, Furumatsu K, Yamanaka K, Kato T, Fujigaki S, Tanaka H, Yagi Y, Tanaka T, Kobayashi T, Masuda A, Shiomi H, Kodama Y
J Gastroenterol 2024 May;59(5):424-433. Epub 2024 Feb 29 doi: 10.1007/s00535-024-02083-1. PMID: 38421473Free PMC Article
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048).
Basch E, Dueck AC, Mitchell SA, Mamon H, Weiser M, Saltz L, Gollub M, Rogak L, Ginos B, Mazza GL, Colgrove B, Chang G, Minasian L, Denicoff A, Thanarajasingam G, Musher B, George T, Venook A, Farma J, O'Reilly E, Meyerhardt JA, Shi Q, Schrag D
J Clin Oncol 2023 Jul 20;41(21):3724-3734. Epub 2023 Jun 4 doi: 10.1200/JCO.23.00903. PMID: 37270691Free PMC Article
A Multi-centre, Single Arm, Non-randomized, Prospective European Trial to Evaluate the Safety and Efficacy of the HistoSonics System in the Treatment of Primary and Metastatic Liver Cancers (#HOPE4LIVER).
Wah TM, Pech M, Thormann M, Serres X, Littler P, Stenberg B, Lenton J, Smith J, Wiggermann P, Planert M, Vidal-Jove J, Torzilli G, Solbiati L
Cardiovasc Intervent Radiol 2023 Feb;46(2):259-267. Epub 2022 Nov 15 doi: 10.1007/s00270-022-03309-6. PMID: 36380155Free PMC Article
Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.
Coleman RL, Brady MF, Herzog TJ, Sabbatini P, Armstrong DK, Walker JL, Kim BG, Fujiwara K, Tewari KS, O'Malley DM, Davidson SA, Rubin SC, DiSilvestro P, Basen-Engquist K, Huang H, Chan JK, Spirtos NM, Ashfaq R, Mannel RS
Lancet Oncol 2017 Jun;18(6):779-791. Epub 2017 Apr 21 doi: 10.1016/S1470-2045(17)30279-6. PMID: 28438473Free PMC Article
Predicting asparaginase-associated pancreatitis.
Knoderer HM, Robarge J, Flockhart DA
Pediatr Blood Cancer 2007 Oct 15;49(5):634-9. doi: 10.1002/pbc.21037. PMID: 16937362

Diagnosis

Characteristics of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review.
Nakane T, Mitsuyama K, Yamauchi R, Kakuma T, Torimura T
Kurume Med J 2023 Jul 3;68(2):43-52. Epub 2023 Apr 26 doi: 10.2739/kurumemedj.MS682006. PMID: 37100606
Improving Palliative Care and Quality of Life in Pancreatic Cancer Patients.
Chung V, Sun V, Ruel N, Smith TJ, Ferrell BR
J Palliat Med 2022 May;25(5):720-727. Epub 2021 Oct 26 doi: 10.1089/jpm.2021.0187. PMID: 34704841Free PMC Article
Hepatobiliary and Pancreatic Adverse Events.
Zhang HC, Wang LS, Miller E
Adv Exp Med Biol 2021;1342:339-355. doi: 10.1007/978-3-030-79308-1_13. PMID: 34972973
Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.
Coleman RL, Brady MF, Herzog TJ, Sabbatini P, Armstrong DK, Walker JL, Kim BG, Fujiwara K, Tewari KS, O'Malley DM, Davidson SA, Rubin SC, DiSilvestro P, Basen-Engquist K, Huang H, Chan JK, Spirtos NM, Ashfaq R, Mannel RS
Lancet Oncol 2017 Jun;18(6):779-791. Epub 2017 Apr 21 doi: 10.1016/S1470-2045(17)30279-6. PMID: 28438473Free PMC Article
Predicting asparaginase-associated pancreatitis.
Knoderer HM, Robarge J, Flockhart DA
Pediatr Blood Cancer 2007 Oct 15;49(5):634-9. doi: 10.1002/pbc.21037. PMID: 16937362

Therapy

Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048).
Basch E, Dueck AC, Mitchell SA, Mamon H, Weiser M, Saltz L, Gollub M, Rogak L, Ginos B, Mazza GL, Colgrove B, Chang G, Minasian L, Denicoff A, Thanarajasingam G, Musher B, George T, Venook A, Farma J, O'Reilly E, Meyerhardt JA, Shi Q, Schrag D
J Clin Oncol 2023 Jul 20;41(21):3724-3734. Epub 2023 Jun 4 doi: 10.1200/JCO.23.00903. PMID: 37270691Free PMC Article
A Multi-centre, Single Arm, Non-randomized, Prospective European Trial to Evaluate the Safety and Efficacy of the HistoSonics System in the Treatment of Primary and Metastatic Liver Cancers (#HOPE4LIVER).
Wah TM, Pech M, Thormann M, Serres X, Littler P, Stenberg B, Lenton J, Smith J, Wiggermann P, Planert M, Vidal-Jove J, Torzilli G, Solbiati L
Cardiovasc Intervent Radiol 2023 Feb;46(2):259-267. Epub 2022 Nov 15 doi: 10.1007/s00270-022-03309-6. PMID: 36380155Free PMC Article
Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study.
Fulgenzi CAM, Cheon J, D'Alessio A, Nishida N, Ang C, Marron TU, Wu L, Saeed A, Wietharn B, Cammarota A, Pressiani T, Personeni N, Pinter M, Scheiner B, Balcar L, Napolitano A, Huang YH, Phen S, Naqash AR, Vivaldi C, Salani F, Masi G, Bettinger D, Vogel A, Schönlein M, von Felden J, Schulze K, Wege H, Galle PR, Kudo M, Rimassa L, Singal AG, Sharma R, Cortellini A, Gaillard VE, Chon HJ, Pinato DJ
Eur J Cancer 2022 Nov;175:204-213. Epub 2022 Sep 20 doi: 10.1016/j.ejca.2022.08.024. PMID: 36148739
Improving Palliative Care and Quality of Life in Pancreatic Cancer Patients.
Chung V, Sun V, Ruel N, Smith TJ, Ferrell BR
J Palliat Med 2022 May;25(5):720-727. Epub 2021 Oct 26 doi: 10.1089/jpm.2021.0187. PMID: 34704841Free PMC Article
Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.
Coleman RL, Brady MF, Herzog TJ, Sabbatini P, Armstrong DK, Walker JL, Kim BG, Fujiwara K, Tewari KS, O'Malley DM, Davidson SA, Rubin SC, DiSilvestro P, Basen-Engquist K, Huang H, Chan JK, Spirtos NM, Ashfaq R, Mannel RS
Lancet Oncol 2017 Jun;18(6):779-791. Epub 2017 Apr 21 doi: 10.1016/S1470-2045(17)30279-6. PMID: 28438473Free PMC Article

Prognosis

Characteristics of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review.
Nakane T, Mitsuyama K, Yamauchi R, Kakuma T, Torimura T
Kurume Med J 2023 Jul 3;68(2):43-52. Epub 2023 Apr 26 doi: 10.2739/kurumemedj.MS682006. PMID: 37100606
Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study.
Fulgenzi CAM, Cheon J, D'Alessio A, Nishida N, Ang C, Marron TU, Wu L, Saeed A, Wietharn B, Cammarota A, Pressiani T, Personeni N, Pinter M, Scheiner B, Balcar L, Napolitano A, Huang YH, Phen S, Naqash AR, Vivaldi C, Salani F, Masi G, Bettinger D, Vogel A, Schönlein M, von Felden J, Schulze K, Wege H, Galle PR, Kudo M, Rimassa L, Singal AG, Sharma R, Cortellini A, Gaillard VE, Chon HJ, Pinato DJ
Eur J Cancer 2022 Nov;175:204-213. Epub 2022 Sep 20 doi: 10.1016/j.ejca.2022.08.024. PMID: 36148739
Clinical Characteristics and Outcomes of Gastritis Associated With Immune Checkpoint Inhibitors: Scoping Review.
Obeidat A, Silangcruz K, Kozai L, Wien E, Fujiwara Y, Nishimura Y
J Immunother 2022 Oct 1;45(8):363-369. Epub 2022 Aug 16 doi: 10.1097/CJI.0000000000000435. PMID: 35972801
Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.
Coleman RL, Brady MF, Herzog TJ, Sabbatini P, Armstrong DK, Walker JL, Kim BG, Fujiwara K, Tewari KS, O'Malley DM, Davidson SA, Rubin SC, DiSilvestro P, Basen-Engquist K, Huang H, Chan JK, Spirtos NM, Ashfaq R, Mannel RS
Lancet Oncol 2017 Jun;18(6):779-791. Epub 2017 Apr 21 doi: 10.1016/S1470-2045(17)30279-6. PMID: 28438473Free PMC Article
Predicting asparaginase-associated pancreatitis.
Knoderer HM, Robarge J, Flockhart DA
Pediatr Blood Cancer 2007 Oct 15;49(5):634-9. doi: 10.1002/pbc.21037. PMID: 16937362

Clinical prediction guides

A prospective registry study of stereotactic magnetic resonance guided radiotherapy (MRgRT) for primary liver tumors.
Bordeau K, Michalet M, Dorion V, Keskes A, Valdenaire S, Debuire P, Cantaloube M, Cabaillé M, Draghici R, Ychou M, Assenat E, Jarlier M, Gourgou S, Guiu B, Ursic-Bedoya J, Aillères N, Fenoglietto P, Azria D, Riou O
Radiother Oncol 2023 Dec;189:109912. Epub 2023 Sep 20 doi: 10.1016/j.radonc.2023.109912. PMID: 37739315
Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study.
Fulgenzi CAM, Cheon J, D'Alessio A, Nishida N, Ang C, Marron TU, Wu L, Saeed A, Wietharn B, Cammarota A, Pressiani T, Personeni N, Pinter M, Scheiner B, Balcar L, Napolitano A, Huang YH, Phen S, Naqash AR, Vivaldi C, Salani F, Masi G, Bettinger D, Vogel A, Schönlein M, von Felden J, Schulze K, Wege H, Galle PR, Kudo M, Rimassa L, Singal AG, Sharma R, Cortellini A, Gaillard VE, Chon HJ, Pinato DJ
Eur J Cancer 2022 Nov;175:204-213. Epub 2022 Sep 20 doi: 10.1016/j.ejca.2022.08.024. PMID: 36148739
Clinical Characteristics and Outcomes of Gastritis Associated With Immune Checkpoint Inhibitors: Scoping Review.
Obeidat A, Silangcruz K, Kozai L, Wien E, Fujiwara Y, Nishimura Y
J Immunother 2022 Oct 1;45(8):363-369. Epub 2022 Aug 16 doi: 10.1097/CJI.0000000000000435. PMID: 35972801
Improving Palliative Care and Quality of Life in Pancreatic Cancer Patients.
Chung V, Sun V, Ruel N, Smith TJ, Ferrell BR
J Palliat Med 2022 May;25(5):720-727. Epub 2021 Oct 26 doi: 10.1089/jpm.2021.0187. PMID: 34704841Free PMC Article
Hepatobiliary and Pancreatic Adverse Events.
Zhang HC, Wang LS, Miller E
Adv Exp Med Biol 2021;1342:339-355. doi: 10.1007/978-3-030-79308-1_13. PMID: 34972973

Recent systematic reviews

Characteristics of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review.
Nakane T, Mitsuyama K, Yamauchi R, Kakuma T, Torimura T
Kurume Med J 2023 Jul 3;68(2):43-52. Epub 2023 Apr 26 doi: 10.2739/kurumemedj.MS682006. PMID: 37100606
Survival benefits from neoadjuvant treatment in gastric cancer: a systematic review and meta-analysis.
Hu J, Yang Y, Ma Y, Ning Y, Chen G, Liu Y
Syst Rev 2022 Jul 4;11(1):136. doi: 10.1186/s13643-022-02001-7. PMID: 35788246Free PMC Article
From palliation to cure: PIPAC for peritoneal malignancies.
Di Giorgio A, Abatini C, Attalla El Halabieh M, Vita E, Vizzielli G, Gallotta V, Pacelli F, Rotolo S
Minerva Med 2019 Aug;110(4):385-398. Epub 2019 May 6 doi: 10.23736/S0026-4806.19.06081-6. PMID: 31081306
Radiation Pneumonitis after Intensity-Modulated Radiotherapy for Esophageal Cancer: Institutional Data and a Systematic Review.
Tonison JJ, Fischer SG, Viehrig M, Welz S, Boeke S, Zwirner K, Klumpp B, Braun LH, Zips D, Gani C
Sci Rep 2019 Feb 19;9(1):2255. doi: 10.1038/s41598-018-38414-5. PMID: 30783157Free PMC Article
Integrative Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Liu Y, May BH, Zhang AL, Guo X, Lu C, Xue CC, Zhang H
Integr Cancer Ther 2019 Jan-Dec;18:1534735418817833. Epub 2018 Dec 10 doi: 10.1177/1534735418817833. PMID: 30526124Free PMC Article

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...